Literature DB >> 8128669

Coping and emotional response in cardiac surgery patients.

C M Crumlish1.   

Abstract

The purpose of this descriptive, correlational study was to examine coping and emotion in patients prior to and after cardiac surgery. The revised Ways of Coping Checklist (WCCL) and the Profile of Mood States (POMS) were completed by 120 patients before surgery and on the fifth postoperative day. Participants had significant (p < .01) differences in coping prior to and following surgery. There were significant (p < .05) postoperative decreases in the use of several coping strategies (seeking social support, blaming oneself, and wishful thinking); however, the use of other coping strategies (problem-focused coping and avoidance) remained unchanged. Emotion did not change. There were positive, significant (p < .05) relationships between several of the coping strategies and perioperative emotion. Preoperative emotion was found to be the best independent predictor of the postoperative emotion.

Entities:  

Mesh:

Year:  1994        PMID: 8128669     DOI: 10.1177/019394599401600105

Source DB:  PubMed          Journal:  West J Nurs Res        ISSN: 0193-9459            Impact factor:   1.967


  3 in total

Review 1.  The association of coping to physical and psychological health outcomes: a meta-analytic review.

Authors:  Julie A Penley; Joe Tomaka; John S Wiebe
Journal:  J Behav Med       Date:  2002-12

2.  Prospective analysis of depression and psychological distress before and after surgical resection of lung cancer.

Authors:  Shiaki Oh; Hideaki Miyamoto; Akio Yamazaki; Ryuta Fukai; Kazu Shiomi; Satoshi Sonobe; Yuichi Saito; Motoki Sakuraba; Toshiro Futagawa; Yukinori Sakao
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-03

3.  Effects of mobile augmented reality learning compared to textbook learning on medical students: randomized controlled pilot study.

Authors:  Urs-Vito Albrecht; Kristian Folta-Schoofs; Marianne Behrends; Ute von Jan
Journal:  J Med Internet Res       Date:  2013-08-20       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.